Horizons 2010, Clare S. Wilkins:

Since 2006, we have administered over 400 Ibogaine treatments for patients representing a cross section of chemical dependencies. We will be presenting on data culled over a four-year period. Outcomes will be measured in terms of detoxification, recidivism, and in some patients, Quality of Life surveys. Preliminary findings demonstrate Ibogaine to be a significant tool in the recovery process, and call for more intensive ...